Search

Your search keyword '"Vieito, Maria"' showing total 108 results
Start Over Author "Vieito, Maria" Database Unpaywall
108 results on '"Vieito, Maria"'

1. Contributors

Author

Aghajani, Samira, primary, Ahmadi, Mazaher, additional, Akimitsu, Nobuyoshi, additional, Aldecoa, Iban, additional, Alves, José Luís, additional, Aran, Veronica, additional, Archilla, Ivan, additional, Arrieta, Oscar, additional, Arora, Geetanjali, additional, Bal, C.S., additional, Balaña, Carmen, additional, Balça-Silva, Joana, additional, Barbosa, Marcos, additional, Basso, João, additional, Behrooz, Amir Barzegar, additional, Bramini, Mattia, additional, Bruno, Francesco, additional, Cabral, Célia, additional, Cardona, Andrés F., additional, Carrato, Cristina, additional, Casalino, Simona, additional, Cascão, Rita, additional, Castagnola, Valentina, additional, Castañer Llanes, Sara, additional, Castelo-Branco, Miguel, additional, Clark, Courtney, additional, Coelho-Santos, Vanessa, additional, Cook, Alexander B., additional, Costa, Bárbara, additional, Costa, Bruno M., additional, Costa, Gustavo, additional, Costabile, Gabriella, additional, Cova, Tânia F.G.G., additional, Dabiri, Seyed Mohammad Hossein, additional, Daher, Ahmad, additional, Delgado, Jéssica, additional, Díaz-Lanza, Ana María, additional, Domenech, Marta, additional, Domínguez-Martín, Eva María, additional, Dubois, Luiz Gustavo, additional, Duskey, Jason T., additional, Efferth, Thomas, additional, Faria, Claudia C., additional, Fortuna, Ana, additional, Garcia-Robledo, Juan Esteban, additional, Ghavami, Saeid, additional, Gimeno, Alfredo, additional, Gomes, Célia M.F., additional, Guerreiro, Joana F., additional, Halder, Ankit, additional, Hernandez, Ainhoa, additional, Hernández Santana, Electra Eduina, additional, Kesari, Santosh, additional, Lopez-Rueda, Antonio, additional, Madrakian, Tayyebeh, additional, Magalhães, Mariana, additional, Manadas, Bruno, additional, Martins, Cláudia, additional, Matias, Diana, additional, Mendes, Filipa, additional, Mendes, Maria, additional, Miller, Donald W., additional, Moran, Teresa, additional, Moreira, Ana, additional, Moreno, Montse, additional, Moschetta, Matteo, additional, Mosquera, Andrés, additional, Moura-Neto, Vivaldo, additional, Mukherjee, Arani, additional, Nunes, Sandra C.C., additional, Oleaga, Laura, additional, Ordoñez, Camila, additional, Pacheco, Catarina, additional, Pais, Alberto A.C.C., additional, Paulo, António, additional, Pellerino, Alessia, additional, Pereira, Mariana, additional, Pineda, Estela, additional, Pinto, Catarina I.G., additional, Prakash, Prasoon, additional, Pronello, Edoardo, additional, Puig, Josep, additional, Ribalta, Teresa, additional, Rijo, Patrícia, additional, Rojas, Katerina, additional, Rudà, Roberta, additional, Saba, Luca, additional, Sarmento, Bruno, additional, Schlich, Michele, additional, Sengupta, Shreoshi, additional, Silva, Fernando, additional, Silva, Francisco, additional, Somasundaram, Kumaravel, additional, Sousa, João, additional, Srivastava, Sanjeeva, additional, Tosi, Giovanni, additional, Trevisani, Martina, additional, Vale, Nuno, additional, Varela, Carla, additional, Verma, Ayushi, additional, Vieito, Maria, additional, Vitorino, Carla, additional, Vitorino, Rui, additional, Walsh, Tavia, additional, and Yathindranath, Vinith, additional

Published
2023
Full Text
View/download PDF

3. Histology-informed liver diffusion MRI: biophysical model design and demonstration in cancer immunotherapy

Author

Grussu, Francesco, primary, Bernatowicz, Kinga, additional, Palombo, Marco, additional, Casanova-Salas, Irene, additional, Barba, Ignasi, additional, Simonetti, Sara, additional, Serna, Garazi, additional, Grigoriou, Athanasios, additional, Voronova, Anna, additional, Garay, Valezka, additional, Corral, Juan Francisco, additional, Vidorreta, Marta, additional, Garcia-Polo Garcia, Pablo, additional, Merino, Xavier, additional, Mast, Richard, additional, Roson, Nuria, additional, Escobar, Manuel, additional, Vieito, Maria, additional, Toledo, Rodrigo, additional, Nuciforo, Paolo, additional, Mateo, Joaquin, additional, Garralda, Elena, additional, and Perez-Lopez, Raquel, additional

Published
2024
Full Text
View/download PDF

5. Identification of Precise 3D CT Radiomics for Habitat Computation by Machine Learning in Cancer

Author

Prior, Olivia, primary, Macarro, Carlos, additional, Navarro, Víctor, additional, Monreal, Camilo, additional, Ligero, Marta, additional, Garcia-Ruiz, Alonso, additional, Serna, Garazi, additional, Simonetti, Sara, additional, Braña, Irene, additional, Vieito, Maria, additional, Escobar, Manuel, additional, Capdevila, Jaume, additional, Byrne, Annette T., additional, Dienstmann, Rodrigo, additional, Toledo, Rodrigo, additional, Nuciforo, Paolo, additional, Garralda, Elena, additional, Grussu, Francesco, additional, Bernatowicz, Kinga, additional, and Perez-Lopez, Raquel, additional

Published
2024
Full Text
View/download PDF

6. RTID-03. A PHASE 1/2 STUDY OF THE WEE1 INHIBITOR DEBIO 0123 IN COMBINATION WITH TEMOZOLOMIDE +- RADIOTHERAPY IN ADULTS WITH RECURRENT OR NEWLY DIAGNOSED GLIOBLASTOMA

Author

Roth, Patrick, primary, Papadopoulos, Kyriakos P, additional, Vieito, Maria, additional, Yang, Jonathan, additional, Majd, Nazanin, additional, Sepúlveda, Juan, additional, Schaff, Lauren, additional, Moreno, Victor, additional, Pérez -Larraya, Jaime Gállego, additional, Micallef, Sandrine, additional, Bellon, Anne, additional, Omar, Mokhtar, additional, Imedio, Esteban Rodrigo, additional, Piggott, Luke, additional, Rodriguez-Freixinos, Victor, additional, and Rodon, Jordi, additional

Published
2023
Full Text
View/download PDF

7. CTIM-25. EO2401 PEPTIDE IMMUNOTHERAPY + NIVOLUMAB +/- BEVACIZUMAB IN FIRST RECURRENT GLIOBLASTOMA: THE PHASE 1/2 EOGBM1-18/ROSALIE STUDY (NCT04116658)

Author

Reardon, David, primary, Idbaih, Ahmed, additional, Vieito, Maria, additional, Ghiringhelli, François, additional, Stradella, Agostina, additional, Tabatabai, Ghazaleh, additional, Burger, Michael C, additional, Mildenberger, Iris, additional, Herrlinger, Ulrich, additional, Wen, Patrick, additional, Touat, Mehdi, additional, Wick, Antje, additional, González, Macarena, additional, Hervieu, Alice, additional, GilMartin, Marta, additional, Renovanz, Mirjam, additional, Gouttefangeas, Cécile, additional, Maia, Ana, additional, Bonny, Christophe, additional, Paillarse, Jean-Michel, additional, Chêne, Laurent, additional, Fagerberg, Jan, additional, and Wick, Wolfgang, additional

Published
2023
Full Text
View/download PDF

8. Supplementary Figure 1 from Phase 1 Study of JNJ-64619178, a Protein Arginine Methyltransferase 5 Inhibitor, in Advanced Solid Tumors

Author

Vieito, Maria, primary, Moreno, Victor, primary, Spreafico, Anna, primary, Brana, Irene, primary, Wang, Judy S., primary, Preis, Meir, primary, Hernández, Tatiana, primary, Genta, Sofia, primary, Hansen, Aaron R., primary, Doger, Bernard, primary, Galvao, Vladimir, primary, Lenox, Laurie, primary, Brown, Regina J., primary, Kalota, Anna, primary, Mehta, Jaydeep, primary, Pastore, Friederike, primary, Patel, Bharvin, primary, Mistry, Pankaj, primary, Gu, Junchen, primary, Lauring, Josh, primary, and Patel, Manish R., primary

Published
2023
Full Text
View/download PDF

9. Supplementary Tables 1-3 from Phase 1 Study of JNJ-64619178, a Protein Arginine Methyltransferase 5 Inhibitor, in Advanced Solid Tumors

Author

Vieito, Maria, primary, Moreno, Victor, primary, Spreafico, Anna, primary, Brana, Irene, primary, Wang, Judy S., primary, Preis, Meir, primary, Hernández, Tatiana, primary, Genta, Sofia, primary, Hansen, Aaron R., primary, Doger, Bernard, primary, Galvao, Vladimir, primary, Lenox, Laurie, primary, Brown, Regina J., primary, Kalota, Anna, primary, Mehta, Jaydeep, primary, Pastore, Friederike, primary, Patel, Bharvin, primary, Mistry, Pankaj, primary, Gu, Junchen, primary, Lauring, Josh, primary, and Patel, Manish R., primary

Published
2023
Full Text
View/download PDF

10. Supplementary Tables 1-3 from Phase 1 Study of JNJ-64619178, a Protein Arginine Methyltransferase 5 Inhibitor, in Advanced Solid Tumors

Author

Vieito, Maria, primary, Moreno, Victor, primary, Spreafico, Anna, primary, Brana, Irene, primary, Wang, Judy S., primary, Preis, Meir, primary, Hernández, Tatiana, primary, Genta, Sofia, primary, Hansen, Aaron R., primary, Doger, Bernard, primary, Galvao, Vladimir, primary, Lenox, Laurie, primary, Brown, Regina J., primary, Kalota, Anna, primary, Mehta, Jaydeep, primary, Pastore, Friederike, primary, Patel, Bharvin, primary, Mistry, Pankaj, primary, Gu, Junchen, primary, Lauring, Josh, primary, and Patel, Manish R., primary

Published
2023
Full Text
View/download PDF

11. Supplementary Figure 1 from Phase 1 Study of JNJ-64619178, a Protein Arginine Methyltransferase 5 Inhibitor, in Advanced Solid Tumors

Author

Vieito, Maria, primary, Moreno, Victor, primary, Spreafico, Anna, primary, Brana, Irene, primary, Wang, Judy S., primary, Preis, Meir, primary, Hernández, Tatiana, primary, Genta, Sofia, primary, Hansen, Aaron R., primary, Doger, Bernard, primary, Galvao, Vladimir, primary, Lenox, Laurie, primary, Brown, Regina J., primary, Kalota, Anna, primary, Mehta, Jaydeep, primary, Pastore, Friederike, primary, Patel, Bharvin, primary, Mistry, Pankaj, primary, Gu, Junchen, primary, Lauring, Josh, primary, and Patel, Manish R., primary

Published
2023
Full Text
View/download PDF

12. Data from Phase 1 Study of JNJ-64619178, a Protein Arginine Methyltransferase 5 Inhibitor, in Advanced Solid Tumors

Author

Vieito, Maria, primary, Moreno, Victor, primary, Spreafico, Anna, primary, Brana, Irene, primary, Wang, Judy S., primary, Preis, Meir, primary, Hernández, Tatiana, primary, Genta, Sofia, primary, Hansen, Aaron R., primary, Doger, Bernard, primary, Galvao, Vladimir, primary, Lenox, Laurie, primary, Brown, Regina J., primary, Kalota, Anna, primary, Mehta, Jaydeep, primary, Pastore, Friederike, primary, Patel, Bharvin, primary, Mistry, Pankaj, primary, Gu, Junchen, primary, Lauring, Josh, primary, and Patel, Manish R., primary

Published
2023
Full Text
View/download PDF

13. Data from Phase 1 Study of JNJ-64619178, a Protein Arginine Methyltransferase 5 Inhibitor, in Advanced Solid Tumors

Author

Vieito, Maria, primary, Moreno, Victor, primary, Spreafico, Anna, primary, Brana, Irene, primary, Wang, Judy S., primary, Preis, Meir, primary, Hernández, Tatiana, primary, Genta, Sofia, primary, Hansen, Aaron R., primary, Doger, Bernard, primary, Galvao, Vladimir, primary, Lenox, Laurie, primary, Brown, Regina J., primary, Kalota, Anna, primary, Mehta, Jaydeep, primary, Pastore, Friederike, primary, Patel, Bharvin, primary, Mistry, Pankaj, primary, Gu, Junchen, primary, Lauring, Josh, primary, and Patel, Manish R., primary

Published
2023
Full Text
View/download PDF

14. Supplemental Table S1 from Tusamitamab Ravtansine in Patients with Advanced Solid Tumors: Phase I Study of Safety, Pharmacokinetics, and Antitumor Activity Using Alternative Dosing Regimens

Author

Tabernero, Josep, primary, Bedard, Philippe L., primary, Bang, Yung-Jue, primary, Vieito, Maria, primary, Ryu, Min-Hee, primary, Fagniez, Nathalie, primary, Chadjaa, Mustapha, primary, Soufflet, Christine, primary, Masson, Nina, primary, and Gazzah, Anas, primary

Published
2023
Full Text
View/download PDF

16. Supplemental Table S3 from Tusamitamab Ravtansine in Patients with Advanced Solid Tumors: Phase I Study of Safety, Pharmacokinetics, and Antitumor Activity Using Alternative Dosing Regimens

Author

Tabernero, Josep, primary, Bedard, Philippe L., primary, Bang, Yung-Jue, primary, Vieito, Maria, primary, Ryu, Min-Hee, primary, Fagniez, Nathalie, primary, Chadjaa, Mustapha, primary, Soufflet, Christine, primary, Masson, Nina, primary, and Gazzah, Anas, primary

Published
2023
Full Text
View/download PDF

18. Supplemental Figure S2 from Tusamitamab Ravtansine in Patients with Advanced Solid Tumors: Phase I Study of Safety, Pharmacokinetics, and Antitumor Activity Using Alternative Dosing Regimens

Author

Tabernero, Josep, primary, Bedard, Philippe L., primary, Bang, Yung-Jue, primary, Vieito, Maria, primary, Ryu, Min-Hee, primary, Fagniez, Nathalie, primary, Chadjaa, Mustapha, primary, Soufflet, Christine, primary, Masson, Nina, primary, and Gazzah, Anas, primary

Published
2023
Full Text
View/download PDF

19. Supplemental Figure S2 from Tusamitamab Ravtansine in Patients with Advanced Solid Tumors: Phase I Study of Safety, Pharmacokinetics, and Antitumor Activity Using Alternative Dosing Regimens

Author

Tabernero, Josep, primary, Bedard, Philippe L., primary, Bang, Yung-Jue, primary, Vieito, Maria, primary, Ryu, Min-Hee, primary, Fagniez, Nathalie, primary, Chadjaa, Mustapha, primary, Soufflet, Christine, primary, Masson, Nina, primary, and Gazzah, Anas, primary

Published
2023
Full Text
View/download PDF

23. Supplemental Table S4 from Tusamitamab Ravtansine in Patients with Advanced Solid Tumors: Phase I Study of Safety, Pharmacokinetics, and Antitumor Activity Using Alternative Dosing Regimens

Author

Tabernero, Josep, primary, Bedard, Philippe L., primary, Bang, Yung-Jue, primary, Vieito, Maria, primary, Ryu, Min-Hee, primary, Fagniez, Nathalie, primary, Chadjaa, Mustapha, primary, Soufflet, Christine, primary, Masson, Nina, primary, and Gazzah, Anas, primary

Published
2023
Full Text
View/download PDF

24. Supplemental Table S1 from Tusamitamab Ravtansine in Patients with Advanced Solid Tumors: Phase I Study of Safety, Pharmacokinetics, and Antitumor Activity Using Alternative Dosing Regimens

Author

Tabernero, Josep, primary, Bedard, Philippe L., primary, Bang, Yung-Jue, primary, Vieito, Maria, primary, Ryu, Min-Hee, primary, Fagniez, Nathalie, primary, Chadjaa, Mustapha, primary, Soufflet, Christine, primary, Masson, Nina, primary, and Gazzah, Anas, primary

Published
2023
Full Text
View/download PDF

25. Supplemental Table S5 from Tusamitamab Ravtansine in Patients with Advanced Solid Tumors: Phase I Study of Safety, Pharmacokinetics, and Antitumor Activity Using Alternative Dosing Regimens

Author

Tabernero, Josep, primary, Bedard, Philippe L., primary, Bang, Yung-Jue, primary, Vieito, Maria, primary, Ryu, Min-Hee, primary, Fagniez, Nathalie, primary, Chadjaa, Mustapha, primary, Soufflet, Christine, primary, Masson, Nina, primary, and Gazzah, Anas, primary

Published
2023
Full Text
View/download PDF

27. Supplemental Table S3 from Tusamitamab Ravtansine in Patients with Advanced Solid Tumors: Phase I Study of Safety, Pharmacokinetics, and Antitumor Activity Using Alternative Dosing Regimens

Author

Tabernero, Josep, primary, Bedard, Philippe L., primary, Bang, Yung-Jue, primary, Vieito, Maria, primary, Ryu, Min-Hee, primary, Fagniez, Nathalie, primary, Chadjaa, Mustapha, primary, Soufflet, Christine, primary, Masson, Nina, primary, and Gazzah, Anas, primary

Published
2023
Full Text
View/download PDF

28. Supplemental Figure S1 from Tusamitamab Ravtansine in Patients with Advanced Solid Tumors: Phase I Study of Safety, Pharmacokinetics, and Antitumor Activity Using Alternative Dosing Regimens

Author

Tabernero, Josep, primary, Bedard, Philippe L., primary, Bang, Yung-Jue, primary, Vieito, Maria, primary, Ryu, Min-Hee, primary, Fagniez, Nathalie, primary, Chadjaa, Mustapha, primary, Soufflet, Christine, primary, Masson, Nina, primary, and Gazzah, Anas, primary

Published
2023
Full Text
View/download PDF

29. Supplemental Table S4 from Tusamitamab Ravtansine in Patients with Advanced Solid Tumors: Phase I Study of Safety, Pharmacokinetics, and Antitumor Activity Using Alternative Dosing Regimens

Author

Tabernero, Josep, primary, Bedard, Philippe L., primary, Bang, Yung-Jue, primary, Vieito, Maria, primary, Ryu, Min-Hee, primary, Fagniez, Nathalie, primary, Chadjaa, Mustapha, primary, Soufflet, Christine, primary, Masson, Nina, primary, and Gazzah, Anas, primary

Published
2023
Full Text
View/download PDF

31. Supplemental Table S5 from Tusamitamab Ravtansine in Patients with Advanced Solid Tumors: Phase I Study of Safety, Pharmacokinetics, and Antitumor Activity Using Alternative Dosing Regimens

Author

Tabernero, Josep, primary, Bedard, Philippe L., primary, Bang, Yung-Jue, primary, Vieito, Maria, primary, Ryu, Min-Hee, primary, Fagniez, Nathalie, primary, Chadjaa, Mustapha, primary, Soufflet, Christine, primary, Masson, Nina, primary, and Gazzah, Anas, primary

Published
2023
Full Text
View/download PDF

33. Supplemental Table S2 from Tusamitamab Ravtansine in Patients with Advanced Solid Tumors: Phase I Study of Safety, Pharmacokinetics, and Antitumor Activity Using Alternative Dosing Regimens

Author

Tabernero, Josep, primary, Bedard, Philippe L., primary, Bang, Yung-Jue, primary, Vieito, Maria, primary, Ryu, Min-Hee, primary, Fagniez, Nathalie, primary, Chadjaa, Mustapha, primary, Soufflet, Christine, primary, Masson, Nina, primary, and Gazzah, Anas, primary

Published
2023
Full Text
View/download PDF

34. Supplemental Figure S1 from Tusamitamab Ravtansine in Patients with Advanced Solid Tumors: Phase I Study of Safety, Pharmacokinetics, and Antitumor Activity Using Alternative Dosing Regimens

Author

Tabernero, Josep, primary, Bedard, Philippe L., primary, Bang, Yung-Jue, primary, Vieito, Maria, primary, Ryu, Min-Hee, primary, Fagniez, Nathalie, primary, Chadjaa, Mustapha, primary, Soufflet, Christine, primary, Masson, Nina, primary, and Gazzah, Anas, primary

Published
2023
Full Text
View/download PDF

35. Supplemental Table S2 from Tusamitamab Ravtansine in Patients with Advanced Solid Tumors: Phase I Study of Safety, Pharmacokinetics, and Antitumor Activity Using Alternative Dosing Regimens

Author

Tabernero, Josep, primary, Bedard, Philippe L., primary, Bang, Yung-Jue, primary, Vieito, Maria, primary, Ryu, Min-Hee, primary, Fagniez, Nathalie, primary, Chadjaa, Mustapha, primary, Soufflet, Christine, primary, Masson, Nina, primary, and Gazzah, Anas, primary

Published
2023
Full Text
View/download PDF

37. Supplemental Table S3 from Tusamitamab ravtansine in patients with advanced solid tumors: Phase 1 study of safety, pharmacokinetics, and antitumor activity using alternative dosing regimens

Author

Tabernero, Josep, primary, Bedard, Philippe L., primary, Bang, Yung-Jue, primary, Vieito, Maria, primary, Ryu, Min-Hee, primary, Fagniez, Nathalie, primary, Chadjaa, Mustapha, primary, Soufflet, Christine, primary, Masson, Nina, primary, and Gazzah, Anas, primary

Published
2023
Full Text
View/download PDF

38. Supplemental Table S4 from Tusamitamab ravtansine in patients with advanced solid tumors: Phase 1 study of safety, pharmacokinetics, and antitumor activity using alternative dosing regimens

Author

Tabernero, Josep, primary, Bedard, Philippe L., primary, Bang, Yung-Jue, primary, Vieito, Maria, primary, Ryu, Min-Hee, primary, Fagniez, Nathalie, primary, Chadjaa, Mustapha, primary, Soufflet, Christine, primary, Masson, Nina, primary, and Gazzah, Anas, primary

Published
2023
Full Text
View/download PDF

39. Supplemental Table S1 from Tusamitamab ravtansine in patients with advanced solid tumors: Phase 1 study of safety, pharmacokinetics, and antitumor activity using alternative dosing regimens

Author

Tabernero, Josep, primary, Bedard, Philippe L., primary, Bang, Yung-Jue, primary, Vieito, Maria, primary, Ryu, Min-Hee, primary, Fagniez, Nathalie, primary, Chadjaa, Mustapha, primary, Soufflet, Christine, primary, Masson, Nina, primary, and Gazzah, Anas, primary

Published
2023
Full Text
View/download PDF

40. Tusamitamab ravtansine in patients with advanced solid tumors: Phase 1 study of safety, pharmacokinetics, and antitumor activity using alternative dosing regimens

Author

Tabernero, Josep, primary, Bedard, Philippe L., additional, Bang, Yung-Jue, additional, Vieito, Maria, additional, Ryu, Min-Hee, additional, Fagniez, Nathalie, additional, Chadjaa, Mustapha, additional, Soufflet, Christine, additional, Masson, Nina, additional, and Gazzah, Anas, additional

Published
2023
Full Text
View/download PDF

41. Supplemental Table S3 from Tusamitamab ravtansine in patients with advanced solid tumors: Phase 1 study of safety, pharmacokinetics, and antitumor activity using alternative dosing regimens

Author

Tabernero, Josep, primary, Bedard, Philippe L., primary, Bang, Yung-Jue, primary, Vieito, Maria, primary, Ryu, Min-Hee, primary, Fagniez, Nathalie, primary, Chadjaa, Mustapha, primary, Soufflet, Christine, primary, Masson, Nina, primary, and Gazzah, Anas, primary

Published
2023
Full Text
View/download PDF

42. Supplemental Table S1 from Tusamitamab ravtansine in patients with advanced solid tumors: Phase 1 study of safety, pharmacokinetics, and antitumor activity using alternative dosing regimens

Author

Tabernero, Josep, primary, Bedard, Philippe L., primary, Bang, Yung-Jue, primary, Vieito, Maria, primary, Ryu, Min-Hee, primary, Fagniez, Nathalie, primary, Chadjaa, Mustapha, primary, Soufflet, Christine, primary, Masson, Nina, primary, and Gazzah, Anas, primary

Published
2023
Full Text
View/download PDF

43. Supplemental Figure S1 from Tusamitamab ravtansine in patients with advanced solid tumors: Phase 1 study of safety, pharmacokinetics, and antitumor activity using alternative dosing regimens

Author

Tabernero, Josep, primary, Bedard, Philippe L., primary, Bang, Yung-Jue, primary, Vieito, Maria, primary, Ryu, Min-Hee, primary, Fagniez, Nathalie, primary, Chadjaa, Mustapha, primary, Soufflet, Christine, primary, Masson, Nina, primary, and Gazzah, Anas, primary

Published
2023
Full Text
View/download PDF

45. Supplemental Table S5 from Tusamitamab ravtansine in patients with advanced solid tumors: Phase 1 study of safety, pharmacokinetics, and antitumor activity using alternative dosing regimens

Author

Tabernero, Josep, primary, Bedard, Philippe L., primary, Bang, Yung-Jue, primary, Vieito, Maria, primary, Ryu, Min-Hee, primary, Fagniez, Nathalie, primary, Chadjaa, Mustapha, primary, Soufflet, Christine, primary, Masson, Nina, primary, and Gazzah, Anas, primary

Published
2023
Full Text
View/download PDF

47. Supplemental Table S2 from Tusamitamab ravtansine in patients with advanced solid tumors: Phase 1 study of safety, pharmacokinetics, and antitumor activity using alternative dosing regimens

Author

Tabernero, Josep, primary, Bedard, Philippe L., primary, Bang, Yung-Jue, primary, Vieito, Maria, primary, Ryu, Min-Hee, primary, Fagniez, Nathalie, primary, Chadjaa, Mustapha, primary, Soufflet, Christine, primary, Masson, Nina, primary, and Gazzah, Anas, primary

Published
2023
Full Text
View/download PDF

48. Supplemental Table S4 from Tusamitamab ravtansine in patients with advanced solid tumors: Phase 1 study of safety, pharmacokinetics, and antitumor activity using alternative dosing regimens

Author

Tabernero, Josep, primary, Bedard, Philippe L., primary, Bang, Yung-Jue, primary, Vieito, Maria, primary, Ryu, Min-Hee, primary, Fagniez, Nathalie, primary, Chadjaa, Mustapha, primary, Soufflet, Christine, primary, Masson, Nina, primary, and Gazzah, Anas, primary

Published
2023
Full Text
View/download PDF

49. Supplemental Table S2 from Tusamitamab ravtansine in patients with advanced solid tumors: Phase 1 study of safety, pharmacokinetics, and antitumor activity using alternative dosing regimens

Author

Tabernero, Josep, primary, Bedard, Philippe L., primary, Bang, Yung-Jue, primary, Vieito, Maria, primary, Ryu, Min-Hee, primary, Fagniez, Nathalie, primary, Chadjaa, Mustapha, primary, Soufflet, Christine, primary, Masson, Nina, primary, and Gazzah, Anas, primary

Published
2023
Full Text
View/download PDF

50. Supplemental Figure S2 from Tusamitamab ravtansine in patients with advanced solid tumors: Phase 1 study of safety, pharmacokinetics, and antitumor activity using alternative dosing regimens

Author

Tabernero, Josep, primary, Bedard, Philippe L., primary, Bang, Yung-Jue, primary, Vieito, Maria, primary, Ryu, Min-Hee, primary, Fagniez, Nathalie, primary, Chadjaa, Mustapha, primary, Soufflet, Christine, primary, Masson, Nina, primary, and Gazzah, Anas, primary

Published
2023
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results